Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ALEX SUAREZ MENDEZ

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1427610369
CMS profile
10667725
Location
BUCKEYE, AZ

General Payments · PY2021–2025

$2,152.00

  • Reported across 115 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$602.46

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $602.46 31

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $202.18 13
Otsuka America Pharmaceutical, Inc. $130.58 5
Alkermes, Inc. $117.54 5
E.R. Squibb & Sons, L.L.C. $86.21 5
Neurocrine BioSciences, Inc. $65.95 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $316.81 13
PY2022 $617.84 44
PY2023 $327.95 15
PY2024 $286.94 12
PY2025 $602.46 31

Payment records · PY2025 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $17.93 02/26/2025 Food and Beverage Undisputed 06/30/2026 1222647985 CMS
Alkermes, Inc. $18.44 03/19/2025 Food and Beverage Undisputed 06/30/2026 1222647987 CMS
Alkermes, Inc. $26.86 04/23/2025 Food and Beverage Undisputed 06/30/2026 1222647989 CMS
Alkermes, Inc. $24.04 10/28/2025 Food and Beverage Undisputed 06/30/2026 1222647991 CMS
Alkermes, Inc. $30.27 12/22/2025 Food and Beverage Undisputed 06/30/2026 1222647993 CMS
E.R. Squibb & Sons, L.L.C. $16.33 02/25/2025 Food and Beverage Undisputed 06/30/2026 1184771690 CMS
E.R. Squibb & Sons, L.L.C. $22.30 04/18/2025 Food and Beverage Undisputed 06/30/2026 1184771712 CMS
E.R. Squibb & Sons, L.L.C. $13.80 07/22/2025 Food and Beverage Undisputed 06/30/2026 1184771752 CMS
E.R. Squibb & Sons, L.L.C. $18.18 10/15/2025 Food and Beverage Undisputed 06/30/2026 1184771784 CMS
E.R. Squibb & Sons, L.L.C. $15.60 11/05/2025 Food and Beverage Undisputed 06/30/2026 1184771782 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.56 02/11/2025 Food and Beverage Undisputed 06/30/2026 1241687122 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.33 04/20/2025 Food and Beverage Undisputed 06/30/2026 1241687124 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.64 05/28/2025 Food and Beverage Undisputed 06/30/2026 1241687126 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.30 07/02/2025 Food and Beverage Undisputed 06/30/2026 1241687128 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.77 07/23/2025 Food and Beverage Undisputed 06/30/2026 1241687130 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.83 07/29/2025 Food and Beverage Undisputed 06/30/2026 1241687132 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.25 08/25/2025 Food and Beverage Undisputed 06/30/2026 1241687134 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.41 09/03/2025 Food and Beverage Undisputed 06/30/2026 1241687136 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.52 09/24/2025 Food and Beverage Undisputed 06/30/2026 1241687138 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.92 10/07/2025 Food and Beverage Undisputed 06/30/2026 1241687140 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3.34 10/07/2025 Food and Beverage Undisputed 06/30/2026 1241687142 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.88 10/07/2025 Food and Beverage Undisputed 06/30/2026 1241687144 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.43 10/22/2025 Food and Beverage Undisputed 06/30/2026 1241687146 CMS
Neurocrine BioSciences, Inc. $17.23 02/10/2025 Food and Beverage Undisputed 06/30/2026 1242905299 CMS
Neurocrine BioSciences, Inc. $16.67 04/15/2025 Food and Beverage Undisputed 06/30/2026 1242908864 CMS
Neurocrine BioSciences, Inc. $32.05 06/23/2025 Food and Beverage Undisputed 06/30/2026 1242821941 CMS
Otsuka America Pharmaceutical, Inc. $26.51 01/21/2025 Food and Beverage Undisputed 06/30/2026 1228004873 CMS
Otsuka America Pharmaceutical, Inc. $24.93 04/22/2025 Food and Beverage Undisputed 06/30/2026 1228004877 CMS
Otsuka America Pharmaceutical, Inc. $26.24 06/02/2025 Food and Beverage Undisputed 06/30/2026 1228004881 CMS
Otsuka America Pharmaceutical, Inc. $25.20 08/06/2025 Food and Beverage Undisputed 06/30/2026 1228004885 CMS
Otsuka America Pharmaceutical, Inc. $27.70 11/04/2025 Food and Beverage Undisputed 06/30/2026 1228004888 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.